CCB International: Upgrade Sino Biopharmaceutical (01801.HK) target price to 128 yuan, maintain "outperform" rating.

According to the Wisdom Financial APP, Industrial Bank International released a research report stating that they have raised the target price of Shinda Biotechnology (01801.HK) from 125 Hong Kong dollars to 128 Hong Kong dollars, an increase of 2.4%, and maintained a "Buy" rating. The bank pointed out that the company has a solid fundamental and is their top pick.